trial · primary record
Raludotatug Deruxtecan
Carcinoma, Non-Small-Cell Lung
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 96 |
| Primary completion | 2032-03-12 |
| Primary endpoint | Objective Response Rate (ORR) |
| Registry ID | NCT06780085 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:46.185Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06780085
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.